Open Access

Tailored treatment for the management of scleral necrosis following pterygium excision

  • Authors:
    • Linna Lu
    • Shiqiong Xu
    • Shengfang Ge
    • Chunyi Shao
    • Zi Wang
    • Xuyang Weng
    • Wenjuan Lu
    • Xinhua Wu
    • Yao Fu
    • Xianqun Fan
  • View Affiliations

  • Published online on: January 12, 2017     https://doi.org/10.3892/etm.2017.4038
  • Pages: 845-850
  • Copyright: © Lu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the efficacy of tailored treatment for the management of scleral necrosis following pterygium surgery. A series of nine cases of scleral necrosis following pterygium excision between September 2009 and September 2012 were included. In cases where ischemia was the cause of scleral necrosis, Tenon's membrane covering (TMC) surgery was performed. For cases with surgically‑induced necrotizing scleritis (SINS), systemic immunosuppressive therapy following surgical repair of the scleral defect was administered in the form of oral prednisolone (starting dose, 30‑60 mg/day). Five patients with ischemic scleral necrosis received TMC postoperatively. Four patients with SINS received various doses of oral prednisolone according to their systematic immune state. All patients had successful postoperative results except one with rheumatoid arthritis, who postoperatively developed scleral patch graft melting within 2 weeks. Following aggressive immunosuppressive treatment, the scleral patch graft was saved. In conclusion, patients achieved positive results using tailored treatment according to the pathogenesis of their scleral necrosis.
View Figures
View References

Related Articles

Journal Cover

March-2017
Volume 13 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lu L, Xu S, Ge S, Shao C, Wang Z, Weng X, Lu W, Wu X, Fu Y, Fan X, Fan X, et al: Tailored treatment for the management of scleral necrosis following pterygium excision. Exp Ther Med 13: 845-850, 2017
APA
Lu, L., Xu, S., Ge, S., Shao, C., Wang, Z., Weng, X. ... Fan, X. (2017). Tailored treatment for the management of scleral necrosis following pterygium excision. Experimental and Therapeutic Medicine, 13, 845-850. https://doi.org/10.3892/etm.2017.4038
MLA
Lu, L., Xu, S., Ge, S., Shao, C., Wang, Z., Weng, X., Lu, W., Wu, X., Fu, Y., Fan, X."Tailored treatment for the management of scleral necrosis following pterygium excision". Experimental and Therapeutic Medicine 13.3 (2017): 845-850.
Chicago
Lu, L., Xu, S., Ge, S., Shao, C., Wang, Z., Weng, X., Lu, W., Wu, X., Fu, Y., Fan, X."Tailored treatment for the management of scleral necrosis following pterygium excision". Experimental and Therapeutic Medicine 13, no. 3 (2017): 845-850. https://doi.org/10.3892/etm.2017.4038